Which sports-related migraine is associated with longer recovery time, as well as cognitive, neurobehavioral, and somatic symptoms? Test your skills in this quiz.
The aim of a randomized controlled trial was to see if aerobic and strength training can successfully slow cognitive decline. The results might surprise you.
Nearly a decade in the making, revised guidelines provide 8 key points for effective nonpharmacologic treatment of epilepsy in childhood.
Exposing the hidden disability through film.
Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.